Por: Newsweek Business February 02, 2023
Pharmaceutical giant Pfizer has been accused of making an obscene profit from the coronavirus pandemic after it posted record revenue of more than $100 billion for 2022, a rise of 23 percent on the previous year.The company's COVID products Comirnaty, an mRNA vaccine and Paxlovid, an oral antiviral, accounted for over $56.7 billion of the company's worldwide revenue. Sales of the two drugs in the U.S. alone accounted for around $19.3... + full article
Associated Press USA Business January 31, 2023
Pfizer surprised Wall Street by predicting a bigger-than-expected sales drop this year for two key products: its COVID-19 vaccine and treatment.The drugmaker also released an earnings forecast that starts off below analyst expectations, sending shares lower before the opening... + más
Fact Check: Were the Grammys sponsored by Pfizer? | Newsweek
Pfizer says COVID-19 vaccine will cost $110-$130 per dose | ABC News
CNBC USA Health January 14, 2023
A patient receives a Covid-19 vaccine booster shot at a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, on Sept. 29, 2021.Emily Elconin ReutersThe Centers for Disease Control and Prevention on Friday said it is very unlikely the Pfizer omicron booster carries a risk... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
Ars Technica USA Science December 14, 2022
Navigate Filter by topic Settings Front page layout Site theme - Dec 14, 2022 1:57 pm UTC / Pfizer Chairman and CEO Dr. Albert Bourla speaks onstage at the 2022 SXSW Conference at JW Marriott Austin on March 14, 2022, in Austin. Share this story Senator Elizabeth Warren... + más
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC
CNBC USA Health December 06, 2022
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
MarketWatch USA Business November 26, 2022
Rosenberg has been interviewed many times by Barron’s and has made some prescient calls. In late 2011, he compared (MSFT) favorably to (IBM), which had then drawn a big investment from (BRK.A). “Warren Buffett came pretty late to the IBM party,” he said. Microsoft is up... + más
Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven | MarketWatch
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
About iurex | Privacy Policy | Disclaimer |